UPDATE 1-Sanofi, AstraZeneca swap compounds in new twist on open drug R&D

LONDON, Nov 20 (Reuters) - French drugmaker Sanofi and Britain's AstraZeneca said on Friday they had agreed a direct exchange of 210,000 chemical compounds from their respective libraries in a new twist on the drive to boost open innovation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.